カスタム抗体の世界市場:サービス別(抗体開発、抗体生産・精製、抗体断片化・標識)、タイプ別(モノクローナル抗体、ポリクローナル抗体、組み換え抗体、その他のカスタム抗体)、ソース別(マウス、ウサギ、その他のソース)、研究領域別(腫瘍学、感染症、エンドユーザー別(製薬・バイオテクノロジー企業、学術・研究機関、受託研究機関)、地域別(北米、中南米、欧州、アジア太平洋、中東、アフリカ) - 2023年から2033年までGlobal Custom Antibody Market by Service (Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling), by Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Custom Antibodies), by Source (Mice, Rabbit, and Other Sources), by Research Area (Oncology, Infectious Diseases, Neurobiology, Stem Cells, Immunology, Cardiovascular Disease, Other Research Areas) By End User (Pharmaceutical & Biotechnologies Industries, Academic & Research Institutions, Contract Research Organizations), by Region (North America, Latin America, Europe, Asia- Pacific, Middle East, and Africa) - 2023 to 2033 カスタム抗体市場 - レポートのスコープ TMRの調査レポート「世界のカスタム抗体市場」は、2023年から2033年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と... もっと見る
このレポートは受注生産にて作成するため
サマリーカスタム抗体市場 - レポートのスコープTMRの調査レポート「世界のカスタム抗体市場」は、2023年から2033年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調査しています。本レポートでは、2023年を基準年、2033年を予測年として考え、2017年から2033年までの期間における世界のカスタム抗体市場の収益を提供します。また、2023年から2033年までの世界のカスタム抗体市場の複合年間成長率(CAGR %)を掲載しています。 本レポートは、広範な調査を経て作成されました。一次調査では、主要なオピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査の大部分を行った。二次調査では、カスタム抗体市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、および関連文書を参照した。 また、インターネット上の情報源、政府機関の統計データ、ウェブサイト、業界団体なども二次調査の対象とした。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界のカスタム抗体市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは、世界のカスタム抗体市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場関係者だけでなく、世界のカスタム抗体市場への参入を検討している企業にとっても貴重なツールになります。 本レポートは、世界のカスタム抗体市場の競争環境について掘り下げています。世界のカスタム抗体市場で事業を展開する主要企業が特定され、それぞれの企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のカスタム抗体市場のプレーヤーの属性です。 カスタム抗体の世界市場レポートで回答された主要な質問 - 予測期間中、全地域におけるカスタム抗体の売上/収益はどの程度か? - 世界のカスタム抗体市場におけるビジネスチャンスは何か? - 市場における主な促進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大するのはどの地域市場か? - 2033年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントはどこか? - 世界市場で事業を展開するさまざまな企業の市場ポジションはどのようなものか? カスタム抗体市場 - 研究目的と研究アプローチ カスタム抗体の世界市場に関する包括的なレポートは、まず概要から始まり、次に調査範囲と目的について説明しています。本調査の目的、市場で活動する主要ベンダーや流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 読みやすさを考慮し、本レポートは章立てでまとめられ、各セクションはより小さなものに分割されています。本レポートは、グラフと表が適切に配置された包括的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えかけています。また、過去と予測期間終了時の主要セグメントの市場シェアを比較することも可能です。 本レポートでは、世界のカスタム抗体市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2033年末時点の各セグメントごとの市場シェアを提示しています。このような貴重な洞察により、市場関係者は、世界のカスタム抗体市場への投資について、十分な情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Custom Antibody Market Analysis 2018-2022 and Forecast, 2023-2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Service 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Service, 2018-2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service, 2023-2033 5.3.1. Antibody Development 5.3.2. Antibody Production & Purification 5.3.3. Antibody Fragmentation & Labeling 5.4. Y-o-Y Growth Trend Analysis By Service, 2018-2022 5.5. Absolute $ Opportunity Analysis By Service, 2023-2033 6. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018-2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023-2033 6.3.1. Monoclonal Antibodies 6.3.2. Polyclonal Antibodies 6.3.3. Recombinant Antibodies 6.3.4. Other Custom Antibodies 6.4. Y-o-Y Growth Trend Analysis By Type, 2018-2022 6.5. Absolute $ Opportunity Analysis By Type, 2023-2033 7. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Source 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033 7.3.1. Mice 7.3.2. Rabbits 7.3.3. Other Sources 7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022 7.5. Absolute $ Opportunity Analysis By Source , 2023-2033 8. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Research Area 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Research Area, 2018-2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Research Area, 2023-2033 8.3.1. Oncology 8.3.2. Infectious Diseases 8.3.3. Neurobiology 8.3.4. Stem Cells 8.3.5. Immunology 8.3.6. Cardiovascular Disease 8.3.7. Other Research Areas 8.4. Y-o-Y Growth Trend Analysis By Research Area, 2018-2022 8.5. Absolute $ Opportunity Analysis By Research Area, 2023-2033 9. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By End User 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033 9.3.1. Pharmaceutical & Biotechnology Companies 9.3.2. Academic & Research Institutes 9.3.3. Contract Research Organizations 9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022 9.5. Absolute $ Opportunity Analysis By End User, 2023-2033 10. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022 10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. Asia Pacific 10.3.5. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 11.2.1. By Country 11.2.1.1. U.S. 11.2.1.2. Canada 11.2.2. By Service 11.2.3. By Type 11.2.4. By Source 11.2.5. By Research Area 11.2.6. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Service 11.3.3. By Type 11.3.4. By Source 11.3.5. By Research Area 11.3.6. By End User 11.4. Key Takeaways 12. Latin America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Service 12.2.3. By Type 12.2.4. By Source 12.2.5. By Research Area 12.2.6. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Service 12.3.3. By Type 12.3.4. By Source 12.3.5. By Research Area 12.3.6. By End User 12.4. Key Takeaways 13. Europe Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 13.2.1. By Country 13.2.1.1. U.K. 13.2.1.2. Spain 13.2.1.3. Germany 13.2.1.4. Italy 13.2.1.5. France 13.2.1.6. Rest of Europe 13.2.2. By Service 13.2.3. By Type 13.2.4. By Source 13.2.5. By Research Area 13.2.6. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Service 13.3.3. By Type 13.3.4. By Source 13.3.5. By Research Area 13.3.6. By End User 13.4. Key Takeaways 14. Asia Pacific Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. India 14.2.1.4. Rest of Asia Pacific 14.2.2. By Service 14.2.3. By Type 14.2.4. By Source 14.2.5. By Research Area 14.2.6. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Service 14.3.3. By Type 14.3.4. By Source 14.3.5. By Research Area 14.3.6. By End User 14.4. Key Takeaways 15. Middle East and Africa Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 15.2.1. By Country 15.2.1.1. South Africa 15.2.1.2. GCC Countries 15.2.1.3. Rest of Middle East and Africa 15.2.2. By Service 15.2.3. By Type 15.2.4. By Source 15.2.5. By Research Area 15.2.6. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Service 15.3.3. By Type 15.3.4. By Source 15.3.5. By Research Area 15.3.6. By End User 15.4. Key Takeaways 16. Key Countries Custom Antibody Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Service 16.1.2.2. By Type 16.1.2.3. By Source 16.1.2.4. By Research Area 16.1.2.5. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Service 16.2.2.2. By Type 16.2.2.3. By Source 16.2.2.4. By Research Area 16.2.2.5. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Service 16.3.2.2. By Type 16.3.2.3. By Source 16.3.2.4. By Research Area 16.3.2.5. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Service 16.4.2.2. By Type 16.4.2.3. By Source 16.4.2.4. By Research Area 16.4.2.5. By End User 16.5. U.K. 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Service 16.5.2.2. By Type 16.5.2.3. By Source 16.5.2.4. By Research Area 16.5.2.5. By End User 16.6. Spain 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Service 16.6.2.2. By Type 16.6.2.3. By Source 16.6.2.4. By Research Area 16.6.2.5. By End User 16.7. Germany 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Service 16.7.2.2. By Type 16.7.2.3. By Source 16.7.2.4. By Research Area 16.7.2.5. By End User 16.8. Italy 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Service 16.8.2.2. By Type 16.8.2.3. By Source 16.8.2.4. By Research Area 16.8.2.5. By End User 16.9. France 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Service 16.9.2.2. By Type 16.9.2.3. By Source 16.9.2.4. By Research Area 16.9.2.5. By End User 16.10. China 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Service 16.10.2.2. By Type 16.10.2.3. By Source 16.10.2.4. By Research Area 16.10.2.5. By End User 16.11. Japan 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Service 16.11.2.2. By Type 16.11.2.3. By Source 16.11.2.4. By Research Area 16.11.2.5. By End User 16.12. India 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Service 16.12.2.2. By Type 16.12.2.3. By Source 16.12.2.4. By Research Area 16.12.2.5. By End User 16.13. South Africa 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Service 16.13.2.2. By Type 16.13.2.3. By Source 16.13.2.4. By Research Area 16.13.2.5. By End User 16.14. GCC Countries 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Service 16.14.2.2. By Type 16.14.2.3. By Source 16.14.2.4. By Research Area 16.14.2.5. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Service 17.3.3. By Type 17.3.4. By Source 17.3.5. By Research Area 17.3.6. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Thermo Fisher Scientific 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Bio-Rad Laboratories Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Merck Group 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Cell Signaling Technology, Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. GenScript 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. BioLegend 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Abcam Plc 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Agilent Technologies 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Innovagen AB 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Proteogenix 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Bio-Techne 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Creative Diagnostics 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Sino Biological, Inc. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Raybiotech, Inc. 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.15. ProSci Incorporated 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology 図表リストList of TablesTable 1: Global Custom Antibody Market Value (US$ Million) Forecast by Region, 2018-2033 Table 2: Global Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 3: Global Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 4: Global Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 5: Global Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 6: Global Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 7: North America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 8: North America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 9: North America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 10: North America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 11: North America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 12: North America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 13: Latin America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 14: Latin America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 15: Latin America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 16: Latin America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 17: Latin America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 18: Latin America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 19: Europe Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 20: Europe Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 21: Europe Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 22: Europe Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 23: Europe Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 24: Europe Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 25: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 26: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 27: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 28: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 29: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 30: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 31: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 32: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 33: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 34: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 35: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 36: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033
SummaryCustom Antibody Market – Scope of Report Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Custom Antibody Market Analysis 2018-2022 and Forecast, 2023-2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Service 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Service, 2018-2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service, 2023-2033 5.3.1. Antibody Development 5.3.2. Antibody Production & Purification 5.3.3. Antibody Fragmentation & Labeling 5.4. Y-o-Y Growth Trend Analysis By Service, 2018-2022 5.5. Absolute $ Opportunity Analysis By Service, 2023-2033 6. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018-2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023-2033 6.3.1. Monoclonal Antibodies 6.3.2. Polyclonal Antibodies 6.3.3. Recombinant Antibodies 6.3.4. Other Custom Antibodies 6.4. Y-o-Y Growth Trend Analysis By Type, 2018-2022 6.5. Absolute $ Opportunity Analysis By Type, 2023-2033 7. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Source 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033 7.3.1. Mice 7.3.2. Rabbits 7.3.3. Other Sources 7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022 7.5. Absolute $ Opportunity Analysis By Source , 2023-2033 8. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Research Area 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Research Area, 2018-2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Research Area, 2023-2033 8.3.1. Oncology 8.3.2. Infectious Diseases 8.3.3. Neurobiology 8.3.4. Stem Cells 8.3.5. Immunology 8.3.6. Cardiovascular Disease 8.3.7. Other Research Areas 8.4. Y-o-Y Growth Trend Analysis By Research Area, 2018-2022 8.5. Absolute $ Opportunity Analysis By Research Area, 2023-2033 9. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By End User 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033 9.3.1. Pharmaceutical & Biotechnology Companies 9.3.2. Academic & Research Institutes 9.3.3. Contract Research Organizations 9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022 9.5. Absolute $ Opportunity Analysis By End User, 2023-2033 10. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022 10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. Asia Pacific 10.3.5. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 11.2.1. By Country 11.2.1.1. U.S. 11.2.1.2. Canada 11.2.2. By Service 11.2.3. By Type 11.2.4. By Source 11.2.5. By Research Area 11.2.6. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Service 11.3.3. By Type 11.3.4. By Source 11.3.5. By Research Area 11.3.6. By End User 11.4. Key Takeaways 12. Latin America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Service 12.2.3. By Type 12.2.4. By Source 12.2.5. By Research Area 12.2.6. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Service 12.3.3. By Type 12.3.4. By Source 12.3.5. By Research Area 12.3.6. By End User 12.4. Key Takeaways 13. Europe Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 13.2.1. By Country 13.2.1.1. U.K. 13.2.1.2. Spain 13.2.1.3. Germany 13.2.1.4. Italy 13.2.1.5. France 13.2.1.6. Rest of Europe 13.2.2. By Service 13.2.3. By Type 13.2.4. By Source 13.2.5. By Research Area 13.2.6. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Service 13.3.3. By Type 13.3.4. By Source 13.3.5. By Research Area 13.3.6. By End User 13.4. Key Takeaways 14. Asia Pacific Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. India 14.2.1.4. Rest of Asia Pacific 14.2.2. By Service 14.2.3. By Type 14.2.4. By Source 14.2.5. By Research Area 14.2.6. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Service 14.3.3. By Type 14.3.4. By Source 14.3.5. By Research Area 14.3.6. By End User 14.4. Key Takeaways 15. Middle East and Africa Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 15.2.1. By Country 15.2.1.1. South Africa 15.2.1.2. GCC Countries 15.2.1.3. Rest of Middle East and Africa 15.2.2. By Service 15.2.3. By Type 15.2.4. By Source 15.2.5. By Research Area 15.2.6. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Service 15.3.3. By Type 15.3.4. By Source 15.3.5. By Research Area 15.3.6. By End User 15.4. Key Takeaways 16. Key Countries Custom Antibody Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Service 16.1.2.2. By Type 16.1.2.3. By Source 16.1.2.4. By Research Area 16.1.2.5. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Service 16.2.2.2. By Type 16.2.2.3. By Source 16.2.2.4. By Research Area 16.2.2.5. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Service 16.3.2.2. By Type 16.3.2.3. By Source 16.3.2.4. By Research Area 16.3.2.5. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Service 16.4.2.2. By Type 16.4.2.3. By Source 16.4.2.4. By Research Area 16.4.2.5. By End User 16.5. U.K. 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Service 16.5.2.2. By Type 16.5.2.3. By Source 16.5.2.4. By Research Area 16.5.2.5. By End User 16.6. Spain 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Service 16.6.2.2. By Type 16.6.2.3. By Source 16.6.2.4. By Research Area 16.6.2.5. By End User 16.7. Germany 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Service 16.7.2.2. By Type 16.7.2.3. By Source 16.7.2.4. By Research Area 16.7.2.5. By End User 16.8. Italy 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Service 16.8.2.2. By Type 16.8.2.3. By Source 16.8.2.4. By Research Area 16.8.2.5. By End User 16.9. France 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Service 16.9.2.2. By Type 16.9.2.3. By Source 16.9.2.4. By Research Area 16.9.2.5. By End User 16.10. China 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Service 16.10.2.2. By Type 16.10.2.3. By Source 16.10.2.4. By Research Area 16.10.2.5. By End User 16.11. Japan 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Service 16.11.2.2. By Type 16.11.2.3. By Source 16.11.2.4. By Research Area 16.11.2.5. By End User 16.12. India 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Service 16.12.2.2. By Type 16.12.2.3. By Source 16.12.2.4. By Research Area 16.12.2.5. By End User 16.13. South Africa 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Service 16.13.2.2. By Type 16.13.2.3. By Source 16.13.2.4. By Research Area 16.13.2.5. By End User 16.14. GCC Countries 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Service 16.14.2.2. By Type 16.14.2.3. By Source 16.14.2.4. By Research Area 16.14.2.5. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Service 17.3.3. By Type 17.3.4. By Source 17.3.5. By Research Area 17.3.6. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Thermo Fisher Scientific 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Bio-Rad Laboratories Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Merck Group 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Cell Signaling Technology, Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. GenScript 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. BioLegend 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Abcam Plc 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Agilent Technologies 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Innovagen AB 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Proteogenix 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Bio-Techne 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Creative Diagnostics 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Sino Biological, Inc. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Raybiotech, Inc. 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.15. ProSci Incorporated 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology List of Tables/GraphsList of TablesTable 1: Global Custom Antibody Market Value (US$ Million) Forecast by Region, 2018-2033 Table 2: Global Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 3: Global Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 4: Global Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 5: Global Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 6: Global Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 7: North America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 8: North America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 9: North America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 10: North America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 11: North America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 12: North America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 13: Latin America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 14: Latin America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 15: Latin America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 16: Latin America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 17: Latin America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 18: Latin America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 19: Europe Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 20: Europe Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 21: Europe Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 22: Europe Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 23: Europe Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 24: Europe Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 25: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 26: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 27: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 28: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 29: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 30: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033 Table 31: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033 Table 32: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033 Table 33: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033 Table 34: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033 Table 35: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033 Table 36: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Transparency Market Research社の医療分野での最新刊レポート
本レポートと同じKEY WORD(antibodies)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |